why choose us

First received: December 04, 2023

Clinical Trial: Treating Amblyopia With SureSight

Study Status: Completed

Recruit Status: RECRUITING

Condition: Amblyopia

Study Type: INTERVENTIONAL


Official Title: Treating Amblyopia With SureSight

Brief Summary: Patients with visual acuity and ocular characteristics outside the Novasight FDA multi-center study are to perform the same Curesight procedures- including M&S EVA or eETDRS patched acuity, stereo and then utilize the Curesight device 1.5 hours per day, 6 days per week over 3-6 months to determine treatment efficacy.An Eye-Tracking-Based Dichoptic Home Treatment for Amblyopia: A Multicenter Randomized Clinical Trial T. Wygnanski-Jaffe, B. J. Kushner, A. Moshkovitz, M. Belkin, O. Yehezkel and G. CureSight…

Read more